Document is current
Any future updates will be listed below
-
Authors
Zhu, Yongjian
Feng, Bing
Wang, Peng
Wang, Bingzhi
Cai, Wei
Wang, Shuang
Meng, Xuan
Wang, Sicong
Zhao, Xinming
Ma, Xiaohong http://orcid.org/0009-0007-7574-6199
-
Funding
Funding for this research was provided by:
CAMS Innovation Fund for Medical Sciences (No. 2023-I2M-C&T-B-102, No. 2023-I2M-C&T-B-102, No. 2023-I2M-C&T-B-102)
Fundamental Research Funds for the Central Universities (No.3332023027)
- License Information
-
More Information
Article History
Received: 26 February 2024
Accepted: 23 May 2024
First Online: 18 June 2024
<!--Emphasis Type='Bold' removed-->Declarations
:
: The study was conducted in line with the principles of the Declaration of Helsinki, and approved by the Institutional Review Board of the National Cancer Center/Cancer Hospital, Beijing, China (Approval Number: 20/412-2608). Informed consent was obtained from all patients.
: Not applicable.
: SW is an employee of Magnetic Resonance Imaging Research, General Electric Healthcare (China). The remaining authors declare that they have no competing interests.
